We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R

News   Nov 04, 2013

 
Canbex Therapeutics Commences Phase I Clinical Trial of Lead Product VSN16R
 
 
 

RELATED ARTICLES

Computational Models of the Human Lung: Potential for Personalized Medicine & Inhalation Toxicology

News

Combining high-performance computing, high-fidelity modeling, and high-resolution medical imaging, produces simulations that have the potential to contribute to new diagnostic tools and treatment options for respiratory disease.

READ MORE

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE